Fairvalue-Calculator Fairvalue-Calculator
EN DE

Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) Fair Value & Analysis

Healthcare · IN · Market cap ₹592M

Price₹36.07
Fair Value₹29.10
Upside-19.3%
Quality97/100
Evidence: High Range ₹21.83 – ₹36.38

Fair value as of: Jun 29, 2026

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) currently trades at ₹36.07, while our model-based Fair Value estimate is ₹29.10 — implying the stock looks roughly 19.3% overvalued today. We read business quality at 97/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Biofil Chemicals and Pharmaceuticals Limited engages in manufacturing and trading of pharmaceuticals in India. It operates through Pharmaceutical and Chemical divisions. The company offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrous fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and packaging solutions. It also provides job work service for manufacturing pharmaceutical drugs. Biofil Chemicals and Pharmaceuticals Limited was incorporated in 1985 and is based in Indore, India.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Biofil Chemicals and Pharmaceuticals Limited (BIOFILCHEM) undervalued?
As of Jun 29, 2026, our model estimates a fair value of ₹29.10 versus a price of ₹36.07 — about −19% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BIOFILCHEM?
Our 21-model fair value for Biofil Chemicals and Pharmaceuticals Limited is ₹29.10 (as of Jun 29, 2026), built from audited fundamentals. The current price is ₹36.07.
What is the quality score of BIOFILCHEM?
Biofil Chemicals and Pharmaceuticals Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.